Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Coronary revascularisation: Which Medications Cause It? (93 Reports Across 7 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Coronary revascularisation has been reported as an adverse event with 7 different drugs in the FDA's FAERS database, with 93 total reports. 15 of these reports resulted in death.The drugs most commonly associated with Coronary revascularisation are TIROFIBAN, CLOPIDOGREL BISULFATE, and EVOLOCUMAB.

93
Total Reports
7
Drugs Involved
15
Deaths
41
Hospitalizations
60.1 yrs
Average Patient Age
13.8% / 86.2%
Female / Male

Which Drugs Cause Coronary revascularisation Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
TIROFIBAN 21 1.0% 2 0 3
CLOPIDOGREL BISULFATE 14 0.0% 0 8 0
EVOLOCUMAB 14 0.0% 4 7 0
ASPIRIN 12 0.0% 0 7 0
AMLODIPINE\VALSARTAN 5 0.1% 0 5 0
ATORVASTATIN\EZETIMIBE 5 0.4% 0 5 0
NEBIVOLOL 5 0.1% 0 5 0

View all 7 drugs →

Top 3 Drugs Associated With Coronary revascularisation

21 reports
14 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)